Shares of Altamira Therapeutics (CYTO) have been struggling lately and have lost 16.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

FORT COLLINS, Colo., Feb. 16, 2021 /PRNewswire/ -- Cytocom, Inc., a leading biopharmaceutical company creating first second-generation immune therapies, today provided an update regarding its CYTO-200 ...

Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for single-cell analysis and isolation, today shared details of Cyto-Mine® Chroma, the second generation of its ...

Cyto-Mine® can simplify and accelerate your day-to-day operations in cell line development, antibody discovery, and beyond. It’s powered by our picodroplet technology to screen and analyze millions of ...